236006 people have viewed this drug in the last 60 days
Updated 2025-04-26
| Last Update | 2022-08-01 |
| Register Year | 2018 |
| Product Type | Human |
| Drug Type | NCE |
| Scientific Name | DABRAFENIB MESILATE |
| Trade Name | TAFINLAR 75MG CAPSULE(120) |
| Strength Unit | mg |
| Pharmaceutical Form | Capsule, hard |
| Administration Route | Oral use |
| Atc Code1 | L01XE23 |
| Atc Code2 | |
| Size | 0 |
| Size Unit | |
| Package Types | Bottle |
| Package Size | 120 |
| Legal Status | Prescription |
| Product Control | Uncontrolled |
| Distribute Area | Hospital |
| Public price | $17751.8 |
| Shelf Life | 24 Months |
| Marketing Company | NOVARTIS PHARMA SCHWEIZ AG |
| Marketing Country | Switzerland |
| Manufacture Name | Glaxo Operations UK Limited |
| Manufacture Country | United Kingdom |
| Secondry package manufacture | |
| Main Agent | Novartis Saudi Limited |
| Secosnd Agent | |
| Third Agent | |
| Visits | 236006 |
Do not forget, after purchasing the medicine, help us determine the price more accurately, press the button below and adjust the price directly
| Name | Price | Visits | Updated |
|---|---|---|---|
| TAFINLAR 75MG CAPSULE(120) | $17751.8 | 236006 visits | 2022-08-01 |
| TAFINLAR 75MG CAPSULE(28) | $4142.1 | 123187 visits | 2022-08-29 |
| TAFINLAR 50MG CAPSULE(120) | $12091.95 | 297213 visits | 2022-08-29 |
| TAFINLAR 50MG CAPSULE(28) | $2821.45 | 144380 visits | 2022-08-29 |